Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis

Fig. 1

Change in risk of first hospitalisation endpoints by decline in FVC% predicted a all-cause hospitalisation or death, b SSc-related hospitalisation or death and c ER or hospital admission followed by ICU or death. Data collected during the treatment period over 52 weeks. CI, confidence interval; ER, emergency room; FVC, forced vital capacity; HR, hazard ratio; ICU, intensive care unit; SSc, systemic sclerosis

Back to article page